Edition:
United States

Advanced Search

Display
per page
  Report Title Date Provider Type Pgs Price

Astellas Pharma Inc: Business description, financial summary, 3yr and interim financials, key statistics/ratios and historical ratio analysis.

This report is essential reading for any serious investor, providing comprehensive financial information on a company's perfo...

20 Aug 2016 Reuters Investment Profile 12 $20.00

Thomson Reuters Stock Report - Astellas Pharma Inc (4503-TO)

StockReports+ gathers Thomson Reuters independent research, ratings and market data into a single report that optimizes the i...

24 Aug 2016 Thomson Reuters Stock Report 11 $25.00

ASTELLAS PHARMA INC (ALPMY=US) - SHORT AND LONG TERM FORECASTS FOR ACTIVE TRADERS

"www.pechala.com, the world's largest market forecasting firm with subscribers in 83 different countries provide forecasts of...

20 Aug 2016 Pechala's Reports 2 $25.00

"The Economy Matters" Report for ALPMF: the economy's impact on ALPMF's price and risk, featuring the powerful Economic Climate Rating and the new MacroRisk "Stoplight" and Risk Correspondence Score

"The Economy Matters"(r) Reports feature the powerful Economic Climate Rating and MacroRisk "Stoplight" to help you in your a...

16 Aug 2016 MacroRisk Analytics/EconomicInvestor 8 $25.00

"The Economy Matters" Report for ALPMY: the economy's impact on ALPMY's price and risk, featuring the powerful Economic Climate Rating and the new MacroRisk "Stoplight" and Risk Correspondence Score

"The Economy Matters"(r) Reports feature the powerful Economic Climate Rating and MacroRisk "Stoplight" to help you in your a...

16 Aug 2016 MacroRisk Analytics/EconomicInvestor 8 $25.00

Astellas Pharma Inc. (4503) - Financial and Strategic SWOT Analysis Review

Astellas Pharma Inc. (4503) - Financial and Strategic SWOT Analysis Review Summary Astellas Pharma Inc. (Astellas) is one of ...

08 Aug 2016 GlobalData 335 $300.00

Astellas Pharma Inc.

Astellas Pharma Inc. - Strategy and SWOT Report, is a source of comprehensive company data and information. The report cover...

05 Aug 2016 MarketLine 47 $50.00

Astellas Pharma Inc. (TOKYO- 4503)

Astellas Pharma Inc., based in Tokyo, Japan, is a company dedicated to improving the health of people around the world throu...

04 Aug 2016 Acquisdata 18 $15.00

Is Now the Time to Buy Astellas Pharma Inc?

03 Aug 2016 Sadif Analytics Prime 12 $25.00

4503.T - Event Transcript of Astellas Pharma Inc conference call, Jul. 29, 2016 / 1:00AM ET

Edited Event Transcript of 4503.T conference call, Jul. 29, 2016 / 1:00AM ET Boston, Aug 2, 2016 (Thomson StreetEvents)...

29 Jul 2016 Thomson Reuters StreetEvents 16 $75.00